FGF23 and polycystic kidney disease: Pkd1 mutations in mouse models also cause abnormalities of the skeleton [14], [15], [16], [17], [18] and human subjects with polycystic kidney disease appear to have earlier elevation of the bone-derived hormone FGF23 [19].